New drug dotinurad takes on febuxostat in heart health showdown
NCT ID NCT06834230
First seen Dec 12, 2025 · Last updated May 04, 2026 · Updated 20 times
Summary
This study tests whether dotinurad is better than febuxostat at improving blood vessel health in people with both high uric acid and high blood pressure. About 360 adults will take one of the two drugs for 24 weeks. The main goal is to see changes in a measure of artery stiffness called CAVI.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Saga University
RECRUITINGSaga, Saga-ken, 840-8502, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.